Symbicort and Melphalan drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Symbicort (budesonide; formoterol fumarate dihydrate) and Melphalan (melphalan). Common drug interactions include atrial fibrillation among females and deep vein thrombosis among males.
The phase IV clinical study analyzes what interactions people have when they take Symbicort and Melphalan. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.
What is Symbicort?
Symbicort has active ingredients of budesonide; formoterol fumarate dihydrate. It is often used in asthma. eHealthMe is studying from 114,792 Symbicort users. Check the latest studies of Symbicort.
What is Melphalan?
Melphalan has active ingredients of melphalan. eHealthMe is studying from 20,052 Melphalan users. Check the latest studies of Melphalan.
17 people who take Symbicort and Melphalan together, and have interactions are studied.

What are the common drug interactions of Symbicort and Melphalan, by gender? *:
female:
- Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
- Atrial thrombosis (blood clot that develops in an artery)
- Blindness
- Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
- Dysphagia (a condition in which swallowing is difficult or painful)
- Mucosal erosion (peeling off of mucous membrane)
- Odynophagia (painful swallowing, in the mouth (oropharynx) or oesophagus)
- Pyrexia (fever)
- Rash
- Skin lesion
male:
- Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
- Pneumonia
- Haematotoxicity (toxins that destroy red blood cells)
- Haemorrhage urinary tract (bleeding from uterine)
- Infection
- Neuropathy peripheral (surface nerve damage)
- Neutropenia (an abnormally low number of neutrophils)
- Plasma cell myeloma (cancer that begins in plasma cells)
- Pulmonary embolism (blockage of the main artery of the lung)
- Skin haemorrhage (bleeding into skin)
What are the common drug interactions of Symbicort and Melphalan, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
- Atrial thrombosis (blood clot that develops in an artery)
- Blindness
- Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
- Dysphagia (a condition in which swallowing is difficult or painful)
- Mucosal erosion (peeling off of mucous membrane)
- Odynophagia (painful swallowing, in the mouth (oropharynx) or oesophagus)
- Pyrexia (fever)
- Rash
- Skin lesion
60+:
- Pneumonia
- Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
- Death
- Epistaxis (bleed from the nose)
- Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
- Haematotoxicity (toxins that destroy red blood cells)
- Haemorrhage urinary tract (bleeding from uterine)
- Infection
- Pulmonary embolism (blockage of the main artery of the lung)
- Skin haemorrhage (bleeding into skin)
What are the existing conditions these people have? *
- Multiple Myeloma (cancer of the plasma cells): 14 people, 82.35%
- High Blood Pressure: 4 people, 23.53%
- Back Pain: 4 people, 23.53%
- High Blood Cholesterol: 2 people, 11.76%
- Obstructive Airways Disorder (a progressive disease that makes it hard to breathe): 2 people, 11.76%
- Dyslipidaemia (abnormal amount of lipids): 2 people, 11.76%
- Hyperlipidaemia (presence of excess lipids in the blood): 2 people, 11.76%
- Insomnia (sleeplessness): 2 people, 11.76%
- Nausea (feeling of having an urge to vomit): 2 people, 11.76%
- Nausea And Vomiting: 2 people, 11.76%
* Approximation only. Some reports may have incomplete information.
Do you take Symbicort and Melphalan?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Symbicort and Melphalan:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Symbicort:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Melphalan:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Symbicort and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Melphalan and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on budesonide; formoterol fumarate dihydrate and melphalan (the active ingredients of Symbicort and Melphalan, respectively), and Symbicort and Melphalan (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Diprivan cause Ejection Fraction Decreased? - 9 seconds ago
- Could Benadryl cause Constipation? - 16 seconds ago
- Drug Withdrawal Syndrome and Fever - 35 seconds ago
- Could Afinitor cause Faeces Pale? - 37 seconds ago
- Could Benadryl cause Change Of Bowel Habit? - 37 seconds ago
- Dermal Cyst and Nausea - 54 seconds ago
- Renal Failure Aggravated and Pneumonia - a minute ago
- Skin Disorder and Constipation - a minute ago
- Drug interactions of Incruse Ellipta and Coenzyme Q10 - a minute ago
- Could Potassium Chloride cause Muscle Spasms? - a minute ago